enGene Therapeutics ENGN SEC Filings

NASDAQ ENGN
$1.58 -0.05 (-3.07%)
At close: Oct 22, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing enGene Therapeutics Inc. (ENGN) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
14Insider Transaction0001552781-26-000501Sep 24, 2026 8:40 PM
210-QQuarterly & Annual Report0001193125-26-384383Sep 8, 2026 7:36 AM
38-KCurrent Report0001193125-26-384380Sep 8, 2026 7:33 AM
4SCHEDULE 13G/AOthers0002005369-26-000051Aug 13, 2026 11:40 AM
58-KCurrent Report0001193125-26-344559Aug 11, 2026 4:03 PM
63Insider Transaction0000929638-26-002667Jul 22, 2026 8:05 PM
73Insider Transaction0000929638-26-002666Jul 22, 2026 8:05 PM
8SCHEDULE 13GBeneficial Ownership Report0001636587-26-000058Jul 22, 2026 1:14 PM
98-KCurrent Report0001193125-26-307795Jul 17, 2026 8:05 PM
108-KCurrent Report0001193125-26-305418Jul 16, 2026 12:06 PM
118-KCurrent Report0001193125-26-275815Jun 18, 2026 8:06 PM
124Insider Transaction0000929638-26-002263Jun 17, 2026 9:44 PM
134Insider Transaction0000929638-26-002262Jun 17, 2026 9:43 PM
144Insider Transaction0000929638-26-002261Jun 17, 2026 9:41 PM
154Insider Transaction0000929638-26-002260Jun 17, 2026 9:40 PM
164Insider Transaction0000929638-26-002259Jun 17, 2026 9:39 PM
174Insider Transaction0000929638-26-002258Jun 17, 2026 9:38 PM
184Insider Transaction0000929638-26-002257Jun 17, 2026 9:37 PM
194Insider Transaction0000929638-26-002256Jun 17, 2026 9:35 PM
2010-QQuarterly & Annual Report0001193125-26-270386Jun 15, 2026 1:16 PM
218-KCurrent Report0001193125-26-270384Jun 15, 2026 1:14 PM
228-KCurrent Report0001193125-26-265830Jun 10, 2026 8:09 PM
23SCHEDULE 13GBeneficial Ownership Report0001172661-26-002215May 15, 2026 5:12 PM
24ARSOthers0001140361-26-020034May 8, 2026 8:08 PM
25ARSOthers0001140361-26-020034May 8, 2026 8:08 PM
26ARSOthers0001140361-26-020034May 8, 2026 8:08 PM
27DEF 14AOthers0001140361-26-020024May 8, 2026 8:06 PM
28DEF 14AOthers0001140361-26-020024May 8, 2026 8:06 PM
29DEF 14AOthers0001140361-26-020024May 8, 2026 8:06 PM
308-KCurrent Report0001193125-26-210316May 7, 2026 11:11 AM
318-KCurrent Report0001193125-26-210316May 7, 2026 11:11 AM
328-KCurrent Report0001193125-26-210316May 7, 2026 11:11 AM
33SCHEDULE 13G/AOthers0002005369-26-000035May 5, 2026 10:59 AM
348-KCurrent Report0001193125-26-149597Apr 9, 2026 8:02 PM
35S-8Prospectus0001193125-26-098008Mar 9, 2026 4:20 PM
36424B5Prospectus0001193125-26-097563Mar 9, 2026 11:25 AM
378-KCurrent Report0001193125-26-097546Mar 9, 2026 11:15 AM
3810-QQuarterly & Annual Report0001193125-26-097541Mar 9, 2026 11:09 AM
398-KCurrent Report0001193125-26-097534Mar 9, 2026 11:04 AM
40EFFECTOthers9999999995-26-000700Mar 2, 2026 5:15 AM
41CORRESPOthers0001193125-26-074564Feb 26, 2026 4:20 PM
42UPLOADOthers0000000000-26-001921Feb 25, 2026 1:30 PM
43S-3Prospectus0001193125-26-059479Feb 19, 2026 9:25 PM
4410-KQuarterly & Annual Report0001193125-26-059409Feb 19, 2026 9:15 PM
45SCHEDULE 13GBeneficial Ownership Report0001738048-26-000020Feb 17, 2026 11:09 PM
46SCHEDULE 13GBeneficial Ownership Report0001172661-26-001032Feb 17, 2026 8:00 PM
47SCHEDULE 13GBeneficial Ownership Report0001907884-26-000003Feb 17, 2026 5:46 PM
484Insider Transaction0000929638-26-000484Feb 3, 2026 9:13 PM
494Insider Transaction0000929638-26-000484Feb 3, 2026 9:13 PM
504Insider Transaction0000929638-26-000484Feb 3, 2026 9:13 PM
...

enGene Therapeutics Inc. SEC Filings API

Pull enGene Therapeutics Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ENGN&formtype=10-K,10-Q&api_key=YOUR_API_KEY